东富龙收盘下跌1.48%，滚动市盈率61.29倍，总市值91.67亿元

Core Viewpoint - Dongfulong's stock closed at 11.97 yuan, down 1.48%, with a rolling PE ratio of 61.29 times, indicating a higher valuation compared to the industry average [1] Company Overview - Dongfulong Technology Group Co., Ltd. operates in four main segments: bioprocessing, formulation, engineering solutions, and food equipment engineering [1] - The company has over 10,000 pharmaceutical devices and systems serving more than 3,000 well-known pharmaceutical companies across over 50 countries and regions [1] Financial Performance - For Q1 2025, Dongfulong reported revenue of 1.137 billion yuan, a year-on-year increase of 2.58%, while net profit was 20.13 million yuan, a year-on-year decrease of 68.87% [1] - The sales gross margin stood at 24.45% [1] Market Position - Dongfulong's PE ratio of 61.29 times ranks it 93rd in the medical device industry, where the average PE is 48.98 times and the median is 36.16 times [2] - The company experienced a net inflow of 1.7151 million yuan in principal funds on May 9, but had a total outflow of 11.4446 million yuan over the past five days [1]